Richard Mayeux on Nasal administration of amyloid-beta peptide decreases cerebral amyloid burden in a mouse model of Alzheimer's disease.
COMMENT These add strong support to the notion that therapy targeting amyloid-beta may be an effective treatment for Alzheimer's disease. 0 rpm2